Inflammatory arthritis can be reined in by CpG-induced DC-NK cell cross talk

Journal of Experimental Medicine

Volumn 204, Issue 8, 2007, Pages 1911-1922

  Wu, Hsin Jung ^a   Sawaya, Heloisa ^e   Binstadt, Bryce ^a,b   Brickelmaier, Margot ^d   Blasius, Amanda ^f   Gorelik, Leonid ^d   Mahmood, Umar ^e   Weissleder, Ralph ^e   Carulli, John ^d   Benoist, Christophe ^a,c   Mathis, Diane ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d BIOGEN   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8ALPHA ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; INTERLEUKIN 12;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; BLOOD; CELL MOTILITY; DENDRITIC CELL; DRUG INHIBITION; EMBRYO; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; INNATE IMMUNITY; MOLECULE; MOUSE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS; CPG ISLANDS; DENDRITIC CELLS; IMMUNOTHERAPY; INFLAMMATION; INTERFERON TYPE II; INTERLEUKIN-12; KILLER CELLS, NATURAL; MICE; MODELS, BIOLOGICAL; NEUTROPHILS; OLIGONUCLEOTIDES; SIGNAL TRANSDUCTION;

EID: 34547771610     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20070285     Document Type: Article

References (63)

1. Seldin, M.F., C.I. Amos, R. Ward, and P.K. Gregersen. 1999. The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum. 42:1071-1079.
2. Leirisalo-Repo, M. 2005. Early arthritis and infection. Curr. Opin. Rheumatol. 17:433-439.
3. Monach, P.A., C. Benoist, and D. Mathis. 2004. The role of antibodies in mouse models of rheumatoid arthritis, and relevance to human disease. Adv. Immunol. 82:217-248.
4. Gordon, S. 2002. Pattern recognition receptors:doubling up for the innate immune response. Cell. 111:927-930.
5. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335-376.
6. Deng, G.M., I.M. Nilsson, M. Verdrengh, L.V. Collins, and A. Tarkowski. 1999. Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat. Med. 5:702-705.
7. Terato, K., D.S. Harper, M.M. Griffiths, D.L. Hasty, X.J. Ye, M.A. Cremer, and J.M. Seyer. 1995. Collagen-induced arthritis in mice:synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen. Autoimmunity. 22:137-147.
8. Choe, J.Y., B. Crain, S.R. Wu, and M. Corr. 2003. Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by Toll-like receptor 4 signaling. J. Exp. Med. 197:537-542.
9. Krieg, A.M. 2002. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20:709-760.
10. Zeuner, R.A., K.J. Ishii, M.J. Lizak, I. Gursel, H. Yamada, D.M. Klinman, and D. Verthelyi. 2002. Reduction of CpG-induced arthritis by suppressive oligodeoxynucleotides. Arthritis Rheum. 46:2219-2224
11. Binstadt, B.A., P.R. Patel, H. Alencar, P.A. Nigrovic, D.M. Lee, U. Mahmood, R. Weissleder, D. Mathis, and C. Benoist. 2006. Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat. Immunol. 7:284-292.
12. Solomon, S., N. Rajasekaran, E. Jeisy-Walder, S.B. Snapper, and H. Illges. 2005. A crucial role for macrophages in the pathology of K/B x N serum-induced arthritis. Eur. J. Immunol. 35:3064-3073.
13. Ohmura, K., A. Johnsen, A. Ortiz-Lopez, P. Desany, M. Roy, W. Besse, J. Rogus, M. Bogue, A. Puech, M. Lathrop, et al. 2005. Variation in IL-1β gene expression is a major determinant of genetic differences in arthritis aggressivity in mice. Proc. Natl. Acad. Sci. USA. 102:12489-12494.
14. Kim, H.Y., H.J. Kim, H.S. Min, S. Kim, W.S. Park, S.H. Park, and D.H. Chung. 2005. NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor β1 production. J. Exp. Med. 201:41-47.
15. Matsumoto, I., M. Maccioni, D.M. Lee, M. Maurice, B. Simmons, M. Brenner, D. Mathis, and C. Benoist. 2002. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat. Immunol. 3:360-365.
16. Wagner, H. 2004. The immunobiology of the TLR9 subfamily. Trends Immunol. 25:381-386.
17. Verthelyi, D., and R.A. Zeuner. 2003. Differential signaling by CpG DNA in DCs and B cells:not just TLR9. Trends Immunol. 24:519-522.
18. Zitvogel, L. 2002. Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J. Exp. Med. 195:F9-14.
19. Walzer, T., M. Dalod, S.H. Robbins, L. Zitvogel, and E. Vivier. 2005. Natural-killer cells and dendritic cells:" l'union fait la force. Blood. 106:2252-2258.
20. Edwards, A.D., S.S. Diebold, E.M. Slack, H. Tomizawa, H. Hemmi, T. Kaisho, S. Akira, and C. Reis e Sousa. 2003. Toll-like receptor expression in murine DC subsets:lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines. Eur. J. Immunol. 33:827-833.
21. Jung, S., D. Unutmaz, P. Wong, G. Sano, K. De los Santos, T. Sparwasser, S. Wu, S. Vuthoori, K. Ko, F. Zavala, E.G. Pamer, D.R. Littman, and R.A. Lang. 2002. In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity. 17:211-220.
22. Kennedy, M.K., M. Glaccum, S.N. Brown, E.A. Butz, J.L. Viney, M. Embers, N. Matsuki, K. Charrier, L. Sedger, C.R. Willis, et al. 2000. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191:771-780.
23. Dubois, S.P., T.A. Waldmann, and J.R. Muller. 2005. Survival adjustment of mature dendritic cells by IL-15. Proc. Natl. Acad. Sci. USA. 102:8662-8667.
24. Krieg, A.M. 2006. Therapeutic potential of Toll-like receptor 9 activation. Nat. Rev. Drug Discov. 5:471-484.
25. Ronaghy, A., B.J. Prakken, K. Takabayashi, G.S. Firestein, D. Boyle, N.J. Zvailfler, S.T. Roord, S. Albani, D.A. Carson, and E. Raz. 2002. Immunostimulatory DNA sequences influence the course of adjuvant arthritis. J. Immunol. 168:51-56.
26. Hoebe, K., E. Janssen, and B. Beutler. 2004. The interface between innate and adaptive immunity. Nat. Immunol. 5:971-974.
27. Quintana, F.J., A. Rotem, P. Carmi, and I.R. Cohen. 2000. Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice:modulation of spontaneous 60-kDa heat shock protein autoimmunity. J. Immunol. 165:6148-6155.
28. Gilkeson, G.S., P. Ruiz, A.M. Pippen, A.L. Alexander, J.B. Lefkowith, and D.S. Pisetsky. 1996. Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA. J. Exp. Med. 183:1389-1397.
29. Rachmilewitz, D., F. Karmeli, K. Takabayashi, T. Hayashi, L. Leider-Trejo, J. Lee, L.M. Leoni, and E. Raz. 2002. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology. 122:1428-1441.
30. Hessel, E.M., M. Chu, J.O. Lizcano, B. Chang, N. Herman, S.A. Kell, M. Wills-Karp, and R.L. Coffman. 2005. Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction. J. Exp. Med. 202:1563-1573.
31. Mellor, A.L., B. Baban, P.R. Chandler, A. Manlapat, D.J. Kahler, and D.H. Munn. 2005. Cutting edge:CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling. J. Immunol. 175:5601-5605.
32. Katakura, K., J. Lee, D. Rachmilewitz, G. Li, L. Eckmann, and E. Raz. 2005. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J. Clin. Invest. 115:695-702.
33. Obermeier, F., N. Dunger, L. Deml, H. Herfarth, J. Scholmerich, and W. Falk. 2002. CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice. Eur. J. Immunol. 32:2084-2092.
34. Granucci, F., I. Zanoni, N. Pavelka, S.L. Van Dommelen, C.E. Andoniou, F. Belardelli, M.A. Degli Esposti, and P. Ricciardi-Castagnoli. 2004. A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J. Exp. Med. 200:287-295.
35. Zanoni, I., M. Foti, P. Ricciardi-Castagnoli, and F. Granucci. 2005. TLR-dependent activation stimuli associated with Th1 responses confer NK cell stimulatory capacity to mouse dendritic cells. J. Immunol. 175:286-292.
36. Chan, C.W., E. Crafton, H.N. Fan, J. Flook, K. Yoshimura, M. Skarica, D. Brockstedt, T.W. Dubensky, M.F. Stins, L.L. Lanier, et al. 2006. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat. Med. 12:207-213.
37. Uyttenhove, C., L. Pilotte, I. Theate, V. Stroobant, D. Colau, N. Parmentier, T. Boon, and B.J. Van den Eynde. 2003. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat. Med. 9:1269-1274.
38. Wingender, G., N. Garbi, B. Schumak, F. Jungerkes, E. Endl, D. von Bubnoff, J. Steitz, J. Striegler, G. Moldenhauer, T. Tuting, et al. 2006. Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO. Eur. J. Immunol. 36:12-20.
39. Cowdery, J.S., N.J. Boerth, L.A. Norian, P.S. Myung, and G.A. Koretzky. 1999. Differential regulation of the IL-12 p40 promoter and of p40 secretion by CpG DNA and lipopolysaccharide. J. Immunol. 162:6770-6775.
40. Albrecht, I., T. Tapmeier, S. Zimmermann, M. Frey, K. Heeg, and A. Dalpke. 2004. Toll-like receptors differentially induce nucleosome remodelling at the IL-12p40 promoter. EMBO Rep. 5:172-177.
41. Robson, R.L., R.M. McLoughlin, J. Witowski, P. Loetscher, T.S. Wilkinson, S.A. Jones, and N. Topley. 2001. Differential regulation of chemokine production in human peritoneal mesothelial cells: IFN-gamma controls neutrophil migration across the mesothelium in vitro and in vivo. J. Immunol. 167:1028-1038.
42. Bruhl, H., C.D. Cohen, S. Linder, M. Kretzler, D. Schlondorff, and M. Mack. 2003. Post-translational and cell type-specific regulation of CXCR4 expression by cytokines. Eur. J. Immunol. 33:3028-3037.
43. Mauritz, N.J., R. Holmdahl, R. Jonsson, P.H. Van der Meide, A. Scheynius, and L. Klareskog. 1988. Treatment with gamma-interferon triggers the onset of collagen arthritis in mice. Arthritis Rheum. 31:1297-1304.
44. Nakajima, H., H. Takamori, Y. Hiyama, and W. Tsukada. 1990. The effect of treatment with interferon-gamma on type II collagen-induced arthritis. Clin. Exp. Immunol. 81:441-445.
45. Muhl, H., and J. Pfeilschifter. 2003. Anti-inflammatory properties of proinfl ammatory interferon-gamma. Int. Immunopharmacol. 3:1247-1255.
46. Machold, K.P., K. Neumann, and J.S. Smolen. 1992. Recombinant human interferon gamma in the treatment of rheumatoid arthritis: double blind placebo controlled study. Ann. Rheum. Dis. 51:1039-1043.
47. Lemmel, E.M., D. Brackertz, M. Franke, W. Gaus, P.W. Hartl, K. Machalke, H. Mielke, H.J. Obert, H.H. Peter, J. Sieper, et al. 1988. Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-gamma. Rheumatol. Int. 8:87-93.
48. 1992. Double blind controlled phase III multicenter clinical trial with interferon gamma in rheumatoid arthritis. German Lymphokine Study Group. Rheumatol. Int. 12:175-185.
49. Veys, E.M., C.J. Menkes, and P. Emery. 1997. A randomized, double-blind study comparing twenty-four-week treatment with recombinant interferon-gamma versus placebo in the treatment of rheumatoid arthritis. Arthritis Rheum. 40:62-68.
50. Kouskoff, V., A.-S. Korganow, V. Duchatelle, C. Degott, C. Benoist, and D. Mathis. 1996. Organ-specific disease provoked by systemic autoreactivity. Cell. 87:811-822.
51. Friend, D.S., N. Ghildyal, K.F. Austen, M.F. Gurish, R. Matsumoto, and R.L. Stevens. 1996. Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype. J. Cell Biol. 135:279-290.
52. Matsumoto, I., A. Staub, C. Benoist, and D. Mathis. 1999. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science. 286:1732-1735.
53. Liu, N., N. Ohnishi, L. Ni, S. Akira, and K.B. Bacon. 2003. CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells. Nat. Immunol. 4:687-693.
54. Dalton, D.K., S. Pitts-Meek, S. Keshav, I.S. Figari, A. Bradley, and T.A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 259:1739-1742.
55. Mattner, F., J. Magram, J. Ferrante, P. Launois, K. Di Padova, R. Behin, M.K. Gately, J.A. Louis, and G. Alber. 1996. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 26:1553-1559.
56. Kopf, M., H. Baumann, G. Freer, M. Freudenberg, M. Lamers, T. Kishimoto, R. Zinkernagel, H. Bluethmann, and G. Kohler. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature. 368:339-342.
57. Kitamura, D., J. Roes, R. Kuhn, and K. Rajewsky. 1991. A B celldeficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature. 350:423-426.
58. Schorle, H., T. Holtschke, T. Hunig, A. Schimpl, and I. Horak. 1991. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature. 352:621-624.
59. Philpott, K.L., J.L. Viney, G. Kay, S. Rastan, E.M. Gardiner, S. Chae, A.C. Hayday, and M.J. Owen. 1992. Lymphoid development in mice congenitally lacking T cell receptor αβ-expressing cells. Science. 256:1448-1452.
60. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature. 408:740-745.
61. Blasius, A.L., E. Giurisato, M. Cella, R.D. Schreiber, A.S. Shaw, and M. Colonna. 2006. Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J. Immunol. 177:3260-3265.
62. Bost, K.L., and J.D. Clements. 1995. In vivo induction of interleukin-12 mRNA expression after oral immunization with Salmonella dublin or the B subunit of Escherichia coli heat-labile enterotoxin. Infect. Immun. 63:1076-1083.
63. Thornton, S., G.P. Boivin, K.N. Kim, F.D. Finkelman, and R. Hirsch. 2000. Heterogeneous effects of IL-2 on collagen-induced arthritis. J. Immunol. 165:1557-1563